Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%
Lithium
44.51
(0.37%)
Gold
2,671.20
0.35%
Copper
4.21
1.63%
Oil
70.07
2.8%
Bitcoin
94,945.38
(0.95%)
FTSE 100
8,359.41
0.56%
Nikkei 225
39,248.86
1.29%
Dow Jones
44,664.37
(0.24%)
Iron Ore
105.10
0.47%
USD/AUD
0.65
0.07%
Hang Seng
19,746.32
0.82%

Cynata Therapeutics Ltd

CYP

ASX

Cynata Therapeutics Limited (ASX: CYP) is an Australian clinical-stage company at the forefront of stem cell and regenerative medicine. Their focus lies on developing and commercializing a proprietary induced pluripotent stem cell (iPSC) platform technology called Cymerus. This technology holds promise for creating new treatments in areas of high unmet medical need.

Latest Posts

Line Chart with Gradient
Price
$0.215
-0.015 (-6.52%)
At Close 02/12 (AEST)
Related Companies
BOTANIX PHARMACEUTICALS LTD
$BOT
HEXIMA LIMITED.
$HXL
TRAJAN GROUP HOLDINGS LIMITED
$TRJ
ALGORAE PHARMACEUTICALS LIMITED
$1AI
OPTHEA LIMITED
$OPT

Leave a Comment on CYP


Comments for CYP

    Latest Posts

    cynata-therapeutics-asxcyp-completes-recruitment-for-osteoarthritis-clinical-trial-cyp
    Health Care $CYP

    Cynata Therapeutics (ASX:$CYP) completes recruitment for osteoarthritis clinical trial

    Phase 3 SCUIpTOR trial of CYP-004 surpasses target sample size with 321 participants

    December 19, 2023
    cynata-therapeutics-asx-cyp-completes-patient-enrolment-in-diabetic-foot-ulcer-clinical-trial-cyp
    Health Care $CYP

    Cynata Therapeutics (ASX: $CYP) completes patient enrolment in diabetic foot ulcer clinical trial

    Phase 1 trial of CYP-006TK for diabetic foot ulcers reaches patient enrolment milestone

    April 8, 2024

    cynata-therapeutics-asx-cyp-receives-eu-approval-for-phase-2-trial-cyp
    Health Care $CYP

    Cynata Therapeutics (ASX: $CYP) receives EU approval for phase 2 trial

    Regulatory and ethics approval granted for CYP-001 trial in high-risk aGvHD

    March 20, 2024

    cynata-therapeutics-asx-cyp-treats-first-patient-in-phase-2-gvhd-trial-cyp
    Health Care $CYP

    Cynata Therapeutics (ASX: $CYP) treats first patient in phase 2 gvhd trial

    Phase 2 clinical trial of CYP-001 in high-risk acute graft versus host disease commences with first patient treated

    March 5, 2024

    cynata-therapeutics-asx-cyp-reports-positive-initial-data-from-diabetic-foot-ulcer-clinical-trial-cyp
    Health Care $CYP

    Cynata Therapeutics (ASX: $CYP) reports positive initial data from diabetic foot ulcer clinical trial

    CYP-006TK trial shows 87.6% median reduction in wound surface area after 10 weeks

    February 26, 2024

    cynata-therapeutics-asx-cyp-completes-recruitment-for-osteoarthritis-clinical-trial-cyp
    Health Care $CYP

    Cynata Therapeutics (ASX: $CYP) completes recruitment for osteoarthritis clinical trial

    Phase 3 SCUIpTOR trial of CYP-004 surpasses target sample size with 321 participants

    January 14, 2024

    CYP

    $CYP

    Cynata Therapeutics (ASX:$CYP) completes recruitment for osteoarthritis clinical trial

    Phase 3 SCUIpTOR trial of CYP-004 surpasses target sample size with 321 participants

    Related Companies
    BCAL DIAGNOSTICS LIMITED
    $BDX
    ANATARA LIFESCIENCES LTD
    $ANR
    HEXIMA LIMITED.
    $HXL
    ARGENICA THERAPEUTICS LIMITED
    $AGN
    LITTLE GREEN PHARMA LTD
    $LGP

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions